Skip to main content

Table 3 Odds ratios, OR (and 95 % CI) of prostate cancer by quintiles of TAC all foods, TAC from fruits and vegetables, Cancer of the Prostate Sweden

From: Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study

FRAP food only Q1 Q2 Q3 Q4 Q5 p-t rend
 All prostate cancer 294/226 292/228 301/220 308/212 294/226  
 Age and region adjusted OR 1.00 1.02 (0.80–1.31) 1.08 (0.84–1.39) 1.11 (0.87–1.43) 1.02 (0.79–1.31) 0.76
 Fully adjusted OR 1.00 0.98(0.77–1.26) 1.05 (0.82–1.35) 1.09 (0.85–1.40) 1.05 (0.82–1.36) 0.53
 Lethal prostate cancer 51/226 49/228 49/220 42/212 41/226  
 Age and region adjusted OR 1.00 0.98 (0.63–1.51) 1.01(0.65–1.56) 0.91 (0.58–1.43) 0.89 (0.57–1.43) 0.58
 Fully adjusted OR 1.00 0.98 (0.63–1.53) 0.98(0.63–1.53) 0.92 (0.58–1.45) 0.87 (0.55–1.39) 0.52
 Advanced prostate cancer 94/226 103/228 95/220 102/212 105/226  
 Age and region adjusted OR 1.00 1.11 (0.78–1.55) 1.04(0.74–1.47) 1.20 (0.85–1.68) 1.23 (0.88–1.73) 0.20
 Fully adjusted OR 1.00 1.08 (0.77–1.53) 1.02(0.72–1.44) 1.18 (0.83–1.67) 1.23 (0.87–1.74) 0.21
 Localized prostate cancer 201/226 196/228 216/220 212/212 195/226  
 Age and region adjusted OR 1.00 1.01 (0.77–1.33) 1.16 (0.89–1.53) 1.11 (0.84–1.46) 0.96 (0.73–1.26) 0.90
 Fully adjusted OR 1.00 0.96 (0.73–1.27) 1.12 (0.85–1.47) 1.09 (0.82–1.43) 1.00 (0.75–1.32) 0.80
 High-grade prostate cancer 56/226 39/228 47/220 49/212 40/226  
 Age and region adjusted OR 1.00 0.72 (0.46–1.13) 0.88(0.57–1.36) 0.99(0.64–1.52) 0.79(0.50–1.25) 0.64
 Fully adjusted OR 1.00 0.68 (0.43–1.07) 0.83(0.53–1.28) 0.95(0.61–1.48) 0.78(0.49–1.24) 0.63
 Low–grade prostate cancer 134/226 139/228 136/220 146/212 138/226  
 Age and region adjusted OR 1.00 1.06 (0.78–1.44) 1.07 (0.78–1.45) 1.11 (0.81–1.50) 0.99 (0.72–1.35) 0.22
 Fully adjusted OR 1.00 1.02 (0.75–1.39) 1.03 (0.76–1.41) 1.09 (0.80–1.49) 1.04 (0.76–1.42) 0.74
FRAP fruit & vegetables Q1 Q2 Q3 Q4 Q5 p-trend
 All prostate cancer 297/222 277/243 306/213 311/209 295/224  
 Age and region adjusted OR 1.00 0.84(0.66–1.08) 1.06(0.82–1.36) 1.09(0.85–1.39) 0.97(0.76–1.25) 0.50
 Fully adjusted OR 1.00 0.83(0.64–1.07) 1.04(0.80–1.34) 1.07(0.83–1.38) 0.94(0.73–1.22) 0.82
 Lethal prostate cancer 53/222 33/243 52/213 45/209 48/224  
 Age and region adjusted OR 1.00 0.57 (0.36–0.92) 1.01 (0.65–1.54) 0.91 (0.58–1.41) 0.91 (0.59–1.41) 0.74
 Fully adjusted OR 1.00 0.61 (0.38–0.99) 1.13 (0.73–1.77) 1.07 (0.67–1.71) 1.02 (0.65–1.61) 0.39
 Advanced prostate cancer 114/222 77/243 106/213 98/209 102/224  
 Age and region adjusted OR 1.00 0.64 (0.44–0.94) 0.90(0.63–1.30) 0.92(0.64–1.33) 0.91(0.63–1.30) 0.76
 Fully adjusted OR 1.00 0.65(0.46–0.93) 1.01(0.72–1.41) 1.01(0.71–1.42) 0.96(0.68–1.35) 0.49
 Localized prostate cancer 192/222 204/243 205/213 219/209 199/224  
 Age and region adjusted OR 1.00 0.93 (0.71–1.23) 1.09 (0.83–1.44) 1.15 (0.87–1.51) 1.00 (0.76–1.32) 0.67
 Fully adjusted OR 1.00 0.90 (0.68–1.18) 1.04 (0.79–1.38) 1.07 (0.81–1.42) 0.94 (0.71–1.25) 0.95
 High-grade prostate cancer 53/222 27/243 46/213 45/209 58/224  
 Age and region adjusted OR 1.00 0.47(0.28–0.77) 0.88 (0.57–1.37) 0.89 (0.57–1.39) 1.08 (0.71–1.64) 0.12
 Fully adjusted OR 1.00 0.49(0.30–0.82) 0.93 (0.59–1.46) 0.99 (0.62–1.57) 1.13 (0.73–1.76) 0.08
 Low-grade prostate cancer 129/222 149/243 140/213 150/209 124/224  
 Age and region adjusted OR 1.00 0.99 (0.73–1.34) 1.06 (0.78–1.45) 1.15 (0.85–1.57) 0.91 (0.66–1.24) 0.67
 Fully adjusted OR 1.00 0.94 (0.69–1.28) 1.01 (0.73–1.38) 1.09 (0.80–1.50) 0.85 (0.62–1.18) 0.46
  1. Fully adjusted models are adjusted for: age, region, smoking (never, former, current), BMI (categories), education (categories), and energy intake (categories)